We also used mTOR activator to carry out the rescue assay and used mTOR inhibitor to study the effects of miR-769-3p, the results indicate that mTOR may be a promising target for the treatment of neurological diseases caused by KSHV infection and miR-769-3p could be a candidate molecular for anti-KSHV therapy. The gene discussed is MTOR; the disease is nervous system disorder.